<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
-------------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of earliest event reported: September 21, 1998
US DIAGNOSTIC INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-13392 11-3146389
- ---------------------- ---------------- -------------
(State or other juris- (Commission File (IRS Employer
diction of incorporation) Number) I.D. No.)
777 South Flagler Drive, West Palm Beach, Florida 33401
- --------------------------------------------------------------------------------
(Address of principal executive office) (Zip Code)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (561) 832-0006
<PAGE> 2
ITEM 5. OTHER EVENTS
The Company announced on September 21, 1998 that it had successfully
completed the application process for its common stock, $.01 par value per share
("Common Stock") to be transferred from the Nasdaq National Market and listed on
the Nasdaq SmallCap Market beginning September 22, 1998. The Common Stock now
trades on such market.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
US DIAGNOSTIC INC.
Date: September 23, 1998 /s/ Francis J. Harkins, Jr.
----------------------------------
Francis J. Harkins, Jr.
Executive Vice President
